Package 50474-983-86

Brand: rystiggo

Generic: rozanolixizumab
NDC Package

Package Facts

Identity

Package NDC 50474-983-86
Digits Only 5047498386
Product NDC 50474-983
Product ID 50474-983_48d5f5c1-c45c-cb63-e063-6394a90a31c8
Description

1 VIAL, GLASS in 1 CARTON (50474-983-86) / 6 mL in 1 VIAL, GLASS

Marketing

Marketing Status
Marketed Since 2024-07-15
Brand rystiggo
Generic rozanolixizumab
Sample Package No

Linked Drug Pages (1)

RYSTIGGO ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "48d5f5c1-c45c-cb63-e063-6394a90a31c8", "openfda": {"nui": ["N0000194004", "N0000194005"], "unii": ["P7186074QC"], "rxcui": ["2642288", "2642294", "2685614", "2685615", "2685616", "2685617", "2685618", "2685619"], "spl_set_id": ["3c0eb8c2-c042-4954-b451-3baa77f5e6d1"], "pharm_class_epc": ["Neonatal Fc Receptor Blocker [EPC]"], "pharm_class_moa": ["Neonatal Fc Receptor Blockers [MoA]"], "manufacturer_name": ["UCB, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (50474-983-86)  / 6 mL in 1 VIAL, GLASS", "package_ndc": "50474-983-86", "marketing_start_date": "20240715"}], "brand_name": "RYSTIGGO", "product_id": "50474-983_48d5f5c1-c45c-cb63-e063-6394a90a31c8", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Neonatal Fc Receptor Blocker [EPC]", "Neonatal Fc Receptor Blockers [MoA]"], "product_ndc": "50474-983", "generic_name": "ROZANOLIXIZUMAB", "labeler_name": "UCB, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RYSTIGGO", "active_ingredients": [{"name": "ROZANOLIXIZUMAB", "strength": "140 mg/mL"}], "application_number": "BLA761286", "marketing_category": "BLA", "marketing_start_date": "20240614", "listing_expiration_date": "20271231"}